Highly urgent liver transplantation:: Possible impact of donor-recipient ABO matching on the outcome after transplantation

被引:34
作者
Bjoro, K
Ericzon, BG
Kirkegaard, P
Höckerstedt, K
Söderdahl, G
Olausson, M
Foss, A
Schmidt, LE
Isoniemi, H
Brandsæter, B
Friman, S
机构
[1] Univ Oslo, Rikshosp, Dept Med, N-0027 Oslo, Norway
[2] Huddinge Hosp, Dept Transplantat Surg, Stockholm, Sweden
[3] Rigshosp, Dept Transplantat Surg, DK-2100 Copenhagen, Denmark
[4] Univ Helsinki Hosp, Dept Transplantat Surg, Helsinki, Finland
[5] Sahlgrens Univ Hosp, Dept Transplantat & Liver Surg, S-41345 Gothenburg, Sweden
[6] Univ Oslo, Rikshosp, Dept Surg, N-0027 Oslo, Norway
[7] Rigshosp, Dept Hepatol, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1097/01.TP.0000044359.72379.E5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Survival after liver transplantation for fulminant hepatic failure has been reported to be less favorable than survival for patients with chronic liver diseases. Methods. We have studied all patients (n=229) undergoing highly urgent liver transplantation from 1990 to 2001 in the Nordic countries. The impact I of patient and donor characteristics, with emphasis on donor-recipient ABO matching (identical, compatible, incompatible), has been studied. Results. One-year and 3-year patient survival rates were 73% and 70% for the total period and 86% and 78% for the last 4-year period. Patients receiving an ABO-compatible liver allograft had significantly lower patient survival rates than those receiving an ABO-identical donor organ (1-year patient survival rates 66% of vs. 79%, P=0.03). Graft survival rates varied less (1-year graft survival rates of 64% vs. 74%, P=0.09). Patients receiving an ABO-incompatible liver allograft had patient survival rates of 70% at 1 year and 60% at 3 years but low graft survival rates (40% and 30% at 1 and 3 years). In a multiple regression analysis, significant independent predictors of poor patient survival were early year of transplantation, ABO-compatible donor, high donor age, and waiting time more than 3 days and less than 9 days. Conclusion. Survival after highly urgent liver transplantation has improved and is comparable to that observed in patients receiving a liver allograft because of chronic liver disease. Patients receiving an ABO-identical donor organ had significantly higher patient survival rates compared with those receiving an ABO-compatible donor liver.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 24 条
[1]   Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [J].
Adam, R ;
Cailliez, V ;
Majno, P ;
Karam, V ;
McMaster, P ;
Calne, RY ;
O'Grady, J ;
Pichlmayr, R ;
Neuhaus, P ;
Otte, JB ;
Hoeckerstedt, K ;
Bismuth, H .
LANCET, 2000, 356 (9230) :621-627
[2]   Use and outcome of liver transplantation in acetaminophen-induced acute liver failure [J].
Bernal, W ;
Wendon, J ;
Rela, M ;
Heaton, N ;
Williams, R .
HEPATOLOGY, 1998, 27 (04) :1050-1055
[3]  
BERNUAU J, 1991, HEPATOLOGY, V14, pA49
[4]   ORTHOTOPIC LIVER-TRANSPLANTATION IN FULMINANT AND SUBFULMINANT HEPATITIS - THE PAUL-BROUSSE EXPERIENCE [J].
BISMUTH, H ;
SAMUEL, D ;
CASTAING, D ;
ADAM, R ;
SALIBA, F ;
JOHANN, M ;
AZOULAY, D ;
DUCOT, B ;
CHICHE, L .
ANNALS OF SURGERY, 1995, 222 (02) :109-119
[5]  
Bjoro K, 1999, SCAND J GASTROENTERO, V34, P714
[6]   Fulminant hepatic failure:: Outcome after listing for highly urgent liver transplantation -: 12 years experience in the Nordic countries [J].
Brandsæter, B ;
Höckerstedt, K ;
Friman, S ;
Ericzon, BG ;
Kirkegaard, P ;
Isoniemi, H ;
Olausson, M ;
Broome, U ;
Schmidt, L ;
Foss, A ;
Bjoro, K .
LIVER TRANSPLANTATION, 2002, 8 (11) :1055-1062
[7]  
BUSSON M, 1995, TRANSPLANT P, V27, P1157
[8]   ABO blood group incompatibility in liver transplantation: A single-centre experience [J].
Chui, AKK ;
Ling, J ;
McCaughan, GW ;
Painter, D ;
Shun, A ;
Dorney, SFA ;
Mears, DC ;
Sheil, AGR .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1997, 67 (05) :275-278
[9]   Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure.: Effect of high-volume plasmapheresis [J].
Clemmesen, JO ;
Gerbes, AL ;
Gülberg, V ;
Hansen, BA ;
Larsen, FS ;
Skak, C ;
Tygstrup, N ;
Ott, P .
HEPATOLOGY, 1999, 29 (02) :347-355
[10]  
DEVLIN J, 1995, HEPATOLOGY, V21, P1018